Securities code: Acrobiosystems Co.Ltd(301080) securities abbreviation: Acrobiosystems Co.Ltd(301080) Announcement No.: 2022026 Acrobiosystems Co.Ltd(301080)
First quarter report 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important content tips: 1 The board of directors and supervisors shall be jointly and severally liable for any misrepresentation, omission or material misrepresentation of the quarterly report of the board of directors and the board of supervisors, and shall not be jointly and severally liable for any misrepresentation or material omission. 2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) declare that they guarantee the authenticity, accuracy and completeness of the financial information in the quarterly report. 3. Whether the first quarter report has been audited □ yes √ No 1. Main financial data (I) whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
Increase or decrease in the reporting period compared with the same period of the previous year
Operating income (yuan): 114258131978945230641 27.73%
Net profit attributable to shareholders of listed company (yuan) 53500686514063451323 31.66%
Net profit attributable to shareholders of listed company after deducting non recurring loss 541 Changshu Fengfan Power Equipment Co.Ltd(601700) 64054491400 33.58% (yuan)
Net cash flow from operating activities (yuan) 36664835381591319550 130.41%
Basic earnings per share (yuan / share) 0.6688 0.6756 – 1.01%
Diluted earnings per share (yuan / share) 0.6688 0.6756 – 1.01%
Weighted average return on net assets 2.15%, 18.39% – 16.24%
At the end of the reporting period, compared with the end of the previous year
Increase or decrease
Total assets (yuan): 259102471947254478711448 1.82%
Owner’s equity attributable to shareholders of listed company (yuan) 252084290222246697091918 2.18%
According to the income composition of disease application field
The amount of the project from the beginning of the year to the end of the reporting period increased or decreased over the same period of the previous year from the beginning of the year to the end of the reporting period
Income from non covid-19 virus epidemic prevention products 90165595866200109702 45.43%
Covid-19 virus epidemic prevention product revenue 24092536112745120939 – 12.24%
Total operating revenue 114258131978945230641 27.73%
（2） Non recurring profit and loss items and amount √ applicable □ not applicable
Unit: Yuan
Description of the amount of the project in the current reporting period
Gains and losses on disposal of non current assets (including the write off part of the provision for asset impairment) -48802091
Other non operating income and expenditure other than the above -6019204
Less: income tax impact 11127060
Total -65948355–
Details of other profit and loss items that meet the definition of non recurring profit and loss: □ applicable √ not applicable. The company does not have details of other profit and loss items that meet the definition of non recurring profit and loss.
Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable the company does not define the non recurring profit and loss items listed in the explanatory announcement on Information Disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items. （3） Changes and reasons of main accounting data and financial indicators √ applicable □ not applicable
Explanation of the reasons for the year-on-year change in the reporting period
Increase or decrease in the same period of the year
Operating income (yuan): 114258131978945230641 27.73%
The net profit attributable to the shareholders of the listed company (yuan) is 53500686514063451323 31.66%, mainly due to the expansion of business scale
The net profit attributable to shareholders of listed companies after deducting non recurring losses 541 Changshu Fengfan Power Equipment Co.Ltd(601700) 64054491400 33.58% is mainly the net profit (yuan) due to the expansion of business scale
Net cash flow from operating activities (yuan) 36664835381591319550 130.41%, mainly due to the expansion of business scale
Basic earnings per share (yuan / share) 0.6888 0.6756 – 1.01%
Diluted earnings per share (yuan / share) 0.6688 0.6756 – 1.01%
Weighted average return on net assets 2.15%, 18.39% – 16.24%
Ratio at the end of the reporting period to the end of the previous year
Increase or decrease at the end of last year
Total assets (yuan): 259102471947254478711448 1.82%
Owner’s equity attributable to shareholders of listed company (yuan) 252084290222246697091918 2.18%
2、 Shareholder information (I) total number of common shareholders, number of preferred shareholders whose voting rights have been restored and shareholding of top ten shareholders
Unit: shares
Total number of common shareholders at the end of the reporting period
Total number of 10662 prior shareholders (if any) 0
Shareholding of top 10 shareholders
Shareholder name shareholder nature shareholding proportion shareholding quantity holding limited sale condition pledge, marking or freezing
Number of shares in stock status
Chen Yiding: 23.53% natural persons 1882716818827168
Tianjin Acrobiosystems Co.Ltd(301080) enterprise
Management consulting partnership domestic non-state owned legal person 9.99% 79905087990508
Enterprise (limited partnership)
8.92% of natural persons in Miao Jingyun 71384527138452
Yan Changwei domestic natural person 4.66% 37289043728904
Natural persons in Wang Miaochun’s territory 4.53% 36223633622363
Nanjing Gaoke Company Limited(600064) xinjuncheng
5144% of domestic non-state-owned equity 335.5
Partnership (limited partnership) Hangzhou jushang medical equity
Investment fund partnership enterprise domestic non-state-owned legal person 3.72% 29789022978902
Ningbo Lanting vision investment (limited partnership)
Capital partnership (with domestic non-state-owned legal person) 3.14% 25090192509019
Limited partnership) China Industrial And Commercial Bank Of China Limited(601398) shares
0 Co., Ltd. – other 2.69% 2151091 shares
European medical health hybrid securities investment fund Hangzhou Puhua Tianji Equity Investment Management Co., Ltd
Company – non state owned legal person in Xinchang Puhua 2.42% 19390301939030
Jingxin Guzhou health management partnership (yes)
